Craniofacial treatment protocol for a pediatric patient with obstructive sleep apnea and skeletal Class III malocclusion: A 13-year follow-up

Kim, Kyung‐A; Lee, Keun-Ha; Kim, Jung-Eun; Cho, Ha-Nul; Yoon, Hwi Joong; Kim, Su-Jung

doi:10.1016/j.ajodo.2021.02.028

Cited by 4 publications

(3 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mehta et al found an increase in nasal width after MARPE treatment in patients aged 11-15 years; the effects were stable in the short-and long-term [8]. Kim reported that a paediatric patient with OSAHs and skeletal Class malocclusion who underwent MARPE showed considerable improvements in breathing and facial morphology after 13 years of follow-up [9]. The goal of orthodontic treatment is not only a stable occlusal relationship, but also the coordinated beauty of the maxillofacial area.…”

Section: Introductionmentioning

confidence: 99%

“…Previous studies have shown that the midpalate suture does not fuse completely under sustained mechanical force, which makes skeletal expansion possible in adult patients [6]. In a retrospective study, Cho et and facial morphology after 13 years of follow-up [9]. The goal of orthodontic treatment is not only a stable occlusal relationship, but also the coordinated beauty of the maxillofacial area.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The short- and long-term changes of upper airway and facial soft tissue in adult patients treated with Mini- Implant Assisted Rapid Palatal Expansion (MARPE): A systematic review and meta-analysis

Liu

Wang

Jiang

et al. 2023

Preprint

View full text Add to dashboard Cite

Objective: This study aims to assess the short- and long-term changes in the upper airway and facial soft tissue after mini-implant -assisted rapid palatal expansion (MARPE) in nongrowing patients with maxillary transverse deficiency (MTD). Methods: Five electronic databases (PubMed, Scopus, Embase, Web of Science, and Cochrane Library) were searched up to 10 March 2023 without limitations and included studies were identified in accordance with the PICOS principles. The main outcomes were classified into three groups: 1) nasal cavity changes, 2) upper airway volume changes and 3) alar changes. Six reviewers independently completed literature screening, data extraction and quality evaluation. The mean difference (MD) and 95% confidence intervals (CI) were used to assess changes in the main outcomes. Heterogeneity tests, subgroup analyses, sensitivity analyses, and publication bias were also analysed. Result: Overall, 2158 articles were retrieved; 18 articles met the inclusion criteria, and 16 articles were included for data analysis. Nasal cavity width (WMD: 1.58 mm; 95% CI: 0.90, 2.26) and nasal floor width (WMD: 1.88 mm; 95% CI: 0.75, 3.02) increased significantly. While palatopharyngeal volume (WMD: 0.2 cm3, 95% CI: -0.61, 1.00), glossopharyngeal volume (WMD: -0.35 cm3, 95% CI: -1.88, 1.18) and hypopharyngeal volume (WMD: -0.90 cm3; 95% CI: -1.86, 0.06) remained unchanged, nasal cavity volume (WMD: 1.24 cm3, 95% CI: 0.68, 1.81), nasopharyngeal volume (MD: 0.75 cm3, 95% CI: 0.44, 1.06), oropharyngeal volume (WMD: 0.59 cm3, 95% CI: 0.27, 0.92), and total volume of the upper airway (WMD: 1.67 cm3, 95% CI: 0.68, 2.66) increased significantly (P<0.05). Alar width (WMD: 1.47 mm; 95% CI: 0.40, 2.55) and alar base width (WMD: 2.02 mm; 95% CI: 0.26, 3.77) also increased in the short term. Conclusion: MARPE can increase nasal cavity width, nasal cavity volume, nasopharyngeal volume and oropharyngeal volume for nongrowing patients, but has no significant effect on hypopharyngeal volume. In addition, the alar width also increased. However, the studies included in this meta-analysis were mainly retrospective, nonrandomized and small in number, so the findings should be interpreted with caution and high-quality RCTs need to be studied.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The short- and long-term changes of upper airway and facial soft tissue in adult patients treated with Mini- Implant Assisted Rapid Palatal Expansion (MARPE): A systematic review and meta-analysis

Liu

Wang

Jiang

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…Mehta et al found an increase in nasal width after MARPE treatment in patients aged 11–15 years; the effects were stable in the short- and long-term [ 13 ]. Kim reported that a pediatric patient with OSAHs and skeletal Class III malocclusion who underwent MARPE showed considerable improvements in breathing and facial morphology after 13 years of follow-up [ 14 ]. Although some studies have evaluated airway response after MARPE treatment, the exact effects on nongrowing patients remain unknown.…”

Section: Introductionmentioning

confidence: 99%

The short- and long-term changes of upper airway and alar in nongrowing patients treated with Mini-Implant Assisted Rapid Palatal Expansion (MARPE): a systematic review and meta-analysis

Liu,

Wang,

Jiang

et al. 2023

BMC Oral Health

View full text Add to dashboard Cite

Objective This study aims to assess the short- and long-term changes in the upper airway and alar width after mini-implant -assisted rapid palatal expansion (MARPE) in nongrowing patients. Methods Five electronic databases (PubMed, Scopus, Embase, Web of Science, and Cochrane Library) were searched up to 2 August, 2023 based on the PICOS principles. The main outcomes were classified into three groups: 1) nasal cavity changes, 2) upper airway changes and 3) alar changes. The mean difference (MD) and 95% confidence intervals (CI) were used to assess these changes. Heterogeneity tests, subgroup analyses, sensitivity analyses, and publication bias were also analyzed. Result Overall, 22 articles were included for data analysis. Nasal cavity width (WMD: 2.05 mm; 95% CI: 1.10, 3.00) and nasal floor width (WMD: 2.13 mm; 95% CI: 1.16, 3.11) increased significantly. While palatopharyngeal volume (WMD: 0.29 cm3, 95% CI: -0.44, 1.01), glossopharyngeal volume (WMD: 0.30 cm3, 95% CI: -0.29, 0.89) and hypopharyngeal volume (WMD: -0.90 cm3; 95% CI: -1.86, 0.06) remained unchanged, nasal cavity volume (WMD: 1.24 cm3, 95% CI: 0.68, 1.81), nasopharyngeal volume (MD: 0.75 cm3, 95% CI: 0.44, 1.06), oropharyngeal volume (WMD: 0.61 cm3, 95% CI: 0.35, 0.87), and total volume of the upper airway (WMD: 1.67 cm3, 95% CI: 0.68, 2.66) increased significantly. Alar width (WMD: 1.47 mm; 95% CI: 0.40, 2.55) and alar base width (WMD: 1.54 mm; 95% CI: 1.21, 1.87) also increased. Conclusion MARPE can increase nasal cavity width, nasal cavity volume, nasopharyngeal volume and oropharyngeal volume for nongrowing patients, but has no significant effect on hypopharyngeal volume. In addition, the alar width also increased. However, the studies included in this meta-analysis were mainly retrospective, nonrandomized and small in number, so the findings should be interpreted with caution and high-quality RCTs need to be studied.

show abstract

Functional outcomes of maxillary expansion in anatomic phenotypes: Current evidence, clinical protocols and crossroads!

Choi,

Kang,

Kim

et al. 2024

Seminars in Orthodontics

View full text Add to dashboard Cite

Craniofacial treatment protocol for a pediatric patient with obstructive sleep apnea and skeletal Class III malocclusion: A 13-year follow-up

Cited by 4 publications

References 39 publications

The short- and long-term changes of upper airway and facial soft tissue in adult patients treated with Mini- Implant Assisted Rapid Palatal Expansion (MARPE): A systematic review and meta-analysis

The short- and long-term changes of upper airway and facial soft tissue in adult patients treated with Mini- Implant Assisted Rapid Palatal Expansion (MARPE): A systematic review and meta-analysis

The short- and long-term changes of upper airway and alar in nongrowing patients treated with Mini-Implant Assisted Rapid Palatal Expansion (MARPE): a systematic review and meta-analysis

Functional outcomes of maxillary expansion in anatomic phenotypes: Current evidence, clinical protocols and crossroads!

Contact Info

Product

Resources

About